I reported previously (25th Sep) that Israel’s Biop had raised $2.2 million to fund its cervical cancer diagnosis device. Biop has just received US FDA approval for the device, which maps the cervix and identifies cancerous and precancerous cells in epithelial tissues.

https://www.calcalistech.com/ctech/articles/0,7340,L-3752348,00.html